# Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

> **NCT07220876** · NA · RECRUITING · sponsor: **Avisi Technologies Inc.** · enrollment: 165 (estimated)

## Conditions studied

- Open Angle Glaucoma (OAG)

## Interventions

- **DEVICE:** VisiPlate Glaucoma Implant

## Key facts

- **NCT ID:** NCT07220876
- **Lead sponsor:** Avisi Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-07
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07220876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07220876, "Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07220876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*